EUR 0.04
(0.92%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.8 Million AUD | -19469.71% |
2022 | -8.64 Million AUD | -101.52% |
2021 | 439.12 Thousand AUD | 365.51% |
2020 | -241.12 Thousand AUD | 0.0% |
2018 | 1.01 Million AUD | -39.26% |
2017 | 1.91 Million GBP | 234.53% |
2016 | 521.78 Thousand GBP | 226.99% |
2015 | 179.29 Thousand GBP | -84.58% |
2014 | 1.16 Million GBP | 198.0% |
2013 | -1.18 Million GBP | -181.69% |
2012 | -421.34 Thousand AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q2 | -78.88 Thousand AUD | 0.0% |
2023 Q4 | -600.97 Thousand AUD | -861.89% |
2023 Q1 | -78.88 Thousand AUD | 98.53% |
2023 FY | - AUD | -19469.71% |
2023 Q3 | 78.88 Thousand AUD | 200.0% |
2022 Q1 | 583.02 Thousand AUD | 647.11% |
2022 Q4 | -5.36 Million AUD | 0.0% |
2022 Q3 | -5.36 Million AUD | -1019.92% |
2022 Q2 | 583.02 Thousand AUD | -0.0% |
2022 FY | - AUD | -101.52% |
2021 Q1 | 215.95 Thousand AUD | 0.0% |
2021 Q3 | 75.17 Thousand AUD | -65.19% |
2021 Q4 | 78.03 Thousand AUD | 3.81% |
2021 Q2 | 215.95 Thousand AUD | -0.0% |
2021 FY | - AUD | 365.51% |
2020 FY | - AUD | 0.0% |
2019 Q4 | 202.79 Thousand AUD | 0.0% |
2019 Q2 | 419.2 Thousand AUD | 0.12% |
2019 Q1 | 418.7 Thousand AUD | 360.13% |
2019 Q3 | 202.79 Thousand AUD | -51.62% |
2018 Q4 | 90.99 Thousand AUD | -0.0% |
2018 Q3 | 90.99 Thousand AUD | -87.93% |
2018 FY | - AUD | -39.26% |
2018 Q2 | 753.73 Thousand AUD | -8.85% |
2018 Q1 | 826.96 Thousand AUD | 383.39% |
2017 Q1 | -47.49 Thousand AUD | -115.63% |
2017 Q3 | 168.92 Thousand AUD | 436.1% |
2017 Q4 | 171.07 Thousand AUD | 1.27% |
2017 Q2 | -50.26 Thousand AUD | -5.83% |
2017 FY | - GBP | 234.53% |
2016 Q1 | 292.6 Thousand AUD | 10.84% |
2016 Q3 | 303.92 Thousand AUD | 98.84% |
2016 Q4 | 303.92 Thousand AUD | 0.0% |
2016 Q2 | 152.84 Thousand AUD | -47.76% |
2016 FY | - GBP | 226.99% |
2015 FY | - GBP | -84.58% |
2015 Q4 | 263.99 Thousand AUD | 0.0% |
2015 Q3 | 263.99 Thousand AUD | 98.62% |
2015 Q2 | 132.91 Thousand AUD | -0.39% |
2015 Q1 | 133.43 Thousand AUD | -71.44% |
2014 Q3 | 467.24 Thousand AUD | 224.54% |
2014 FY | - GBP | 198.0% |
2014 Q4 | 467.24 Thousand AUD | 0.0% |
2014 Q2 | -375.16 Thousand AUD | 0.0% |
2013 Q2 | -366.49 Thousand AUD | 0.0% |
2013 FY | - GBP | -181.69% |
2012 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AB Science S.A. | -9.28 Million EUR | 80.555% |
Boiron SA | 80.67 Million EUR | 102.237% |
Fagron NV | 141.94 Million EUR | 101.271% |
Ipsen S.A. | 1.14 Billion EUR | 100.158% |
Malin Corporation plc | -3.8 Million EUR | 52.507% |
Vetoquinol SA | 104.58 Million EUR | 101.726% |